CPPI News |

September 13, 2021
By cppiadmin
No Comments

CPPI: HHS Drug Pricing Report’s Importation Plan Misses the Mark

in Consumer Impact, CPPI News, Drug prices

“Congress should act now to ensure personal prescription importation is included in the reconciliation package and protected under the law,” CPPI Executive Director says The Campaign for Personal Prescription Importation (CPPI) released the following statement…

August 30, 2021
By cppiadmin
No Comments

CPPI Statement on Bipartisan Senate Letter Urging Personal Rx Importation Policies

in Consumer Impact, CPPI News, Drug prices

Senators Klobuchar, Grassley, King & Collins Urges Biden Administration to Allow Personal Rx Importation Washington, DC - The Campaign for Personal Prescription Importation (CPPI) today released a statement in support of the bipartisan letter sent…

July 22, 2021
By cppiadmin
No Comments

Politico/Harvard Survey Shows Strong Support for RxImportation From Canada

in Consumer Impact, CPPI News, Drug prices

Washington, DC - The Campaign for Personal Prescription Importation today commented on the results of a POLITICO/Harvard survey that found broad American support for government efforts to allow the importation of less expensive medicines from…

July 21, 2021
By cppiadmin
No Comments

CPPI Statement on Survey Evidence of Increasing Online Rx Purchasing

in Consumer Impact, CPPI News

Washington, D.C. – The Campaign for Personal Prescription Importation (CPPI) today called for Congress to expand access to affordable medicines from online Canadian pharmacies, while highlighting key findings of a new national survey conducted by…

July 21, 2021
By cppiadmin
No Comments

CPPI: Recall of Insulin Re-Importation & Personal Importation Federal Orders Moves America Backwards

in Consumer Impact, CPPI News, Drug prices

Washington, DC - The Campaign for Personal Prescription Importation today commented on the Biden Administration’s withdrawal of the Requests for Proposals for Insulin Reimportation and Personal Prescription Drug Importation. “The withdrawal of policies advancing insulin…

June 30, 2021
By cppiadmin
No Comments

July: A Horrible Month for US Consumers

in Big Pharma, Consumer Impact, CPPI News, Drug prices

What Happens Every July - BigPharma Uses Cover of Holiday to Raise Prices Washington, DC - Every year in the United States, drug manufacturers raise the price of brand-name prescription drugs in January and July.…

June 23, 2021
By cppiadmin
No Comments

National Study Demonstrates True Mortality Toll of Rising Rx Prices

in Consumer Impact, CPPI News, Drug prices

The National Bureau of Economic Research (NBER) published a study this year demonstrating how even small increases in cost cause patients to reduce their use of drugs with major benefits, ultimately causing their death. Other…

June 8, 2021
By cppiadmin
No Comments

CPPI Statement on HHS Importation Case Filing

in Big Pharma, Consumer Impact, CPPI News, Drug prices

BigPharma Has No Case Against Importation Asserts HHS Washington, DC - The Campaign for Personal Prescription Importation released the following statement regarding the Health and Human Services motion to dismiss Case No. 1:20-cv-03402-TJK, regarding a…

May 27, 2021
By cppiadmin
No Comments

American Patients’ Medication Access Constrained by Credit Card Processing

in Consumer Impact, CPPI News, Drug prices

In a survey of American patients who import medications conducted by the Campaign for Personal Prescription Importation, 89% say that lifting restrictions on credit card processing for international online prescription drug purchases would ease access…

May 4, 2021
By cppiadmin
No Comments

GAO Confirms Safety of Drugs From Overseas

in Big Pharma, Consumer Impact, CPPI News, Drug prices, Rogues, Safety

Tens of millions of Americans can't afford their prescription drugs and the debate over how to ensure access to affordable drugs is hotly contested. One of the biggest strawman arguments propped up by Big Pharma…

Category Archives: CPPI News